CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Clinical trial NCT07315087 · RECRUITING

Trial details

NCT number: NCT07315087
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

SLE - Systemic Lupus Erythematosus SSc-Systemic Sclerosis IIM- Idiopathic Inflammatory Myopathies ANCA Associated Vasculitis (AAV)Connective Tissue Disease-Associated Thrombocytopenia SLE-ITP

Start date: 2026-01-01
Primary completion: 2029-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.